相关实验视频
Updated: Jun 15, 2025

04:27
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
5.6K
静脉注射甲基普雷迪尼索隆脉冲在患有后感染性支气管炎的儿童中的有效性
Souad Ghattas1, David Drummond1,2, Alice Hadchouel1,2,3
1AP-HP, Hôpital Universitaire Necker-Enfants Malades, Service de Pneumologie Pédiatrique, Centre de Référence pour les Maladies Respiratoires Rares de l'Enfant, Paris, France.
Pediatric pulmonology
|June 12, 2025
概括
静脉注射甲基普雷迪尼索隆脉冲并没有改善患有后感染性支气管炎消灭症 (PIBO) 的儿童的结局. 这项回顾性研究发现,与未接受治疗的患者相比,没有显著的临床或功能差异.
科学领域:
- 儿科肺病学 儿科肺病学
- 临床免疫学临床免疫学
背景情况:
- 后感染性支气管炎消灭性 (PIBO) 是儿童的一种严重阻塞性肺病.
- 对PIBO的治疗选择仍然有限,需要对有效疗法的研究.
研究的目的:
- 评估静脉注射甲基普雷迪尼索隆脉冲在治疗儿科患者PIBO中的疗效.
- 为了比较治疗和未治疗PIBO患者的临床结果和肺功能.
主要方法:
- 对31名儿科PIBO患者的回顾性分析.
- 在甲基普雷迪尼索隆脉冲接收者和对照组之间比较呼吸系统症状,恶化,住院和肺功能测试.
- 诊断时最严重的患者的子组分析.
主要成果:
- 甲基prednisolone组经历了更长的初始住院时间,更多的ICU入院,以及更大的氧气需求.
- 治疗组中的更多患者在6个月内需要非预定的住院治疗.
- 两组之间没有观察到肺功能测试或临床演变的显著差异,即使在最严重的子组中也是如此.
结论:
- 静脉注射甲基普雷迪尼索隆脉冲在随后发生的严重感染后支气管炎 obliterans的演变中没有益处.
- 研究结果表明,这种治疗策略不会改变PIBO患者的疾病进程.
相关概念视频
Acute Respiratory Failure-V
125
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
125
Inhaled Medications
244
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
244
Pulmonary Cycle: Exhalation
1.5K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.5K
COPD: Management Using Bronchodilators and Corticosteroids
188
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
188
Pneumonia IV: Management
311
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
311
Drugs Used in Lower Respiratory Disorders: Overview
362
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
362

